Lifeboat Foundation

A radical collaboration between a biologist and an engineer is supercharging efforts to protect grape crops. The technology they’ve developed, using robotics and AI to identify grape plants infected with a devastating fungus, will soon be available to researchers nationwide working on a wide array of plant and animal research.

The biologist, Lance Cadle-Davidson, Ph.D. ‘03, an adjunct professor in the School of Integrative Plant Science (SIPS), is working to develop grape varieties that are more resistant to powdery mildew, but his lab’s research was bottlenecked by the need to manually assess thousands of grape leaf samples for evidence of infection.

Powdery mildew, a fungus that attacks many plants including wine and table grapes, leaves sickly white spores across leaves and fruit and costs grape growers worldwide billions of dollars annually in lost fruit and fungicide costs.

Three scientists on Tuesday won the Nobel Physics Prize, including the first woman to receive the prestigious award in 55 years, for inventing Chirped-pulse amplification, or CPA. The 9-million-Swedish-kronor award (about $1 million) will be doled out to Arthur Ashkin of Bell Laboratories in Holmdel, N.J., Gérard Mourou of École Polytechnique in Palaiseau, France, and Donna Strickland of the University of Waterloo in Canada. This is a technique for creating ultrashort, yet extremely high-energy laser pulses necessary in a variety of applications. It is remarkable what can be achieved with lasers in research and in applications, and there are many good reasons for it, including their coherence, frequency stability, and controllability, but for some applications, the thing that really matters is raw power. Article by Dr. Olivier Alirol, Physicist, Resonance Science Foundation Research Scientist.

Circa 2017

It’s often mistaken for a sinking ship by passing boats.

For many years now, China has been the world’s factory. Even in 2,020 as other economies struggled with the effects of the pandemic, China’s manufacturing output was $3.854 trillion, up from the previous year, accounting for nearly a third of the global market.

But if you are still thinking of China’s factories as sweatshops, it’s probably time to change your perception. The Chinese economic recovery from its short-lived pandemic blip has been boosted by its world-beating adoption of artificial intelligence (AI). After overtaking the U.S. in 2,014 China now has a significant lead over the rest of the world in AI patent applications. In academia, China recently surpassed the U.S. in the number of both AI research publications and journal citations. Commercial applications are flourishing: a new wave of automation and AI infusion is crashing across a swath of sectors, combining software, hardware and robotics.

As a society, we have experienced three distinct industrial revolutions: steam power, electricity and information technology. I believe AI is the engine fueling the fourth industrial revolution globally, digitizing and automating everywhere. China is at the forefront in manifesting this unprecedented change.

The Future of Everything covers the innovation and technology transforming the way we live, work and play, with monthly issues on health, money, cities and more. This month is Education & Learning, online starting Aug. 6 and in the paper on Aug. 13.

No one has yet deciphered the brain signals that encode a complex thought, turn an idea into words or make a lasting memory. But powerful clues are emerging to drive the neurotechnology of learning, scientists say.

On the frontier of neuroscience, researchers are inventing devices to enhance learning abilities, from wearable nerve stimulators that boost mental focus to headsets for wireless brain-to-brain communication.

U.S. government commits to purchase approximately 1.7 million courses of Molnupiravir upon issuance of Emergency Use Authorization or approval by the U.S. Food and Drug Administration.

KENILWORTH, N.J. 0 June 17 2021 /PRNewswire/ — Merck (NYSE: MRK), known as MSD outside the United States and Canada 0 today announced it has entered into a procurement agreement with the United States government for Molnupiravir (MK-4482). Molnupiravir is currently being evaluated in a Phase 3 clinical trial, the MOVe-OUT study, for the treatment of non-hospitalized patients with laboratory-confirmed COVID-19 and at least one risk factor associated with poor disease outcomes. MSD is developing Molnupiravir in collaboration with Ridgeback Biotherapeutics.

“MSD is pleased to collaborate with the U.S. government on this new agreement that will provide Americans with COVID-19 access to molnupiravir – an investigational oral therapy being studied for outpatient use early in the course of disease – if it is authorized or approved,” said Rob Davis 0 president, MSD. “In addition to this agreement with the U.S. government, we are actively engaged in numerous efforts to make molnupiravir available globally to fulfill MSD’s commitment to widespread access.”

The high-end Anthénea Floating Condos will hit the seas in early 2022.

The covid-19 pandemic has reinforced humanity’s dependence on modern tech, but the same tools that enable remote working are also being used to spread disinformation and perpetuate cybercrime. Ambivalence towards technology is nothing new.

Read more of our coverage of Science & technology: https://econ.st/3CdkVa5

Continue reading “Should we be worried about technology? | The Economist” »

(March 12 2021)

A digital model has revealed a complex planetarium on the ancient device’s face. “Unless it’s from outer space, we have to find a way in which the Greeks could have made it,” researchers say.